Delivery Order SPE2DB20D3505-SPE2DB25FYCPL
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $33,943.97. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for ultimate completion by September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $25,484.82. The order is scheduled for completion by September 8, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that serves military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $10,940.38. This firm fixed-price delivery order, which is not set-aside and represents the culmination of competitive procurement, is scheduled for completion by August 7, 2025. The award supports the federal medical supply chain, with performance occurring at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a contract ceiling value of $29,588.62. This firm fixed-price delivery order, which is expected to conclude by August 15, 2025, represents a competitively awarded, non-set-aside contract with performance directed to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award demonstrates the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $72,013.58 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages) on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,785.70 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) under a firm fixed price contract. The award was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. This delivery order represents a non-competitive purchase executed under an existing contract vehicle and will be performed at the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $27,320.78. This firm fixed-price delivery order, which is expected to be completed by July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $17,437.91. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a non-competitive set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,932.84 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Otezla 30 mg tablets (60-count packaging) with a ceiling value of $13,807.38. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical vendor. The order is scheduled for completion by September 9, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCPLDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Otezla 30 mg tablets (60-count) with a ceiling value of $13,849.62. This firm fixed price delivery order is non-competitive and carries an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The award represents a child contract under the company's broader relationship with the DLA's medical supply chain. This delivery order falls under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains, with the flexibility to serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 9/17/25 |